Influenza Vaccines Market: Rising Demand for Preventative Healthcare Drives Growth

1
Global Influenza Vaccines Market Is Estimated To
Witness High Growth Owing To Increasing Focus on
Preventive Healthcare Measures
The global Influenza Vaccines market is
estimated to be valued at US 5,965.9 Mn in 2022
and is expected to exhibit a CAGR of 4.2 over
the forecast period 2022-2030, as highlighted in
a new report published by Coherent Market
Insights. A) Market Overview Influenza
vaccines are used to prevent or reduce the
severity of influenza, commonly known as the
flu. These vaccines stimulate the immune system
to produce antibodies that provide protection
against specific influenza viruses. The need for
influenza vaccines arises from the highly
contagious nature and potentially severe health
complications associated with the flu. Influenza
vaccines are one of the most effective ways to
prevent influenza infection and its spread. They
offer several advantages, including reducing the
risk of hospitalization, complications, and
deaths due to influenza. B) Market Key Trends
One key trend in the influenza vaccines market
is the increasing focus on preventive healthcare
measures. With the growing awareness about the
benefits of vaccination and the need to minimize
the impact of infectious diseases, governments
and healthcare organizations are emphasizing on
preventive healthcare measures. This includes
promoting influenza vaccination among high-risk
populations, such as the elderly, pregnant
women, and individuals with underlying health
conditions. Vaccination programs in schools and
workplaces are also being implemented to reduce
the spread of influenza. For example, the
Centers for Disease Control and Prevention (CDC)
in the U.S. recommends annual influenza
vaccination for everyone aged six months and
older. C) PEST Analysis
2
- Political Governments play a crucial role in
shaping influenza vaccination policies,
regulations, and funding. Political stability and
support for healthcare initiatives are key
factors influencing the growth of the influenza
vaccines market. - Economic The bargaining
power of suppliers is high in the Influenza
Vaccines Market. Vaccine manufacturing requires
specialized ingredients and technologies, making
suppliers essential for the industry. economic
factors influencing the market include healthcare
expenditure, affordability of vaccines,
insurance coverage, and healthcare
infrastructure. The affordability and
accessibility of vaccines are essential for the
widespread adoption of influenza vaccination
programs. - Social Social factors include
public awareness, education, cultural beliefs,
and social norms related to vaccination.
Building trust and addressing vaccine hesitancy
are essential for successful influenza
vaccination programs. - Technological
Advancements in vaccine production technologies,
such as the use of cell-based or recombinant DNA
technology, are driving innovation in the
influenza vaccines market. Improved production
efficiencies and shorter manufacturing timelines
are key technological advancements in this
market. D) Key Takeaways - The global
Influenza Vaccines market is expected to witness
high growth, exhibiting a CAGR of 4.2 over the
forecast period, due to increasing focus on
preventive healthcare measures. Governments and
healthcare organizations are promoting influenza
vaccination to minimize the impact of the flu
and reduce healthcare burden. - Regionally,
North America is expected to dominate the
Influenza Vaccines market, owing to
well- established healthcare infrastructure, high
awareness about vaccination, and government
initiatives to promote immunization. - Key
players operating in the global Influenza
Vaccines market include Seqirus, GlaxoSmithKline
plc, Sanofi, AstraZeneca, FluGen, Inc., Moderna,
Inc., Biocryst Pharmaceuticals, Inc., CPL
Biologicals Pvt. Ltd., CureVac AG, OSIVAX, and
Solaris Vaccines. These players focus on product
development, strategic collaborations, and
innovation to maintain their market position.
In conclusion, the global Influenza Vaccines
market is projected to witness significant growth
in the coming years, driven by increasing focus
on preventive healthcare measures and rising
awareness about the importance of influenza
vaccination. Governments, healthcare
organizations, and key players in the market
play a crucial role in promoting vaccination
programs and ensuring the availability and
accessibility of influenza vaccines globally.